The global defibrillators market is expected to grow at a CAGR of 5.2% from 2017-2022. The market is expected to grow at a CAGR of 6.1% from 2017 to 2029. In 2018, the Implantable Cardioverter Defibrillators segment held 77% of the global defibrillators market.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand-new report, you find 179-page report you will receive 74 tables and 125 figures – all unavailable elsewhere.
The 179-page report provides clear detailed insight into the global defibrillators market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand new report today you stay better informed and ready to act.
Report Scope
• Global Defibrillators Market forecast 2019-2029
• Global Defibrillators market forecast by product:
• Implantable Cardioverter Defibrillators (ICDs)
• Transvenous ICDs (T-ICDs)
– Single-Chamber ICDs
– Dual-Chamber ICDs
– Cardiac Resynchronization Therapy Defibrillators (CRT-Ds)
• Subcutaneous ICDs (S-ICDs)
• External Defibrillators
• Manual External Defibrillators
• Automated External Defibrillators (AEDs)
– Semi-Automated External Defibrillators
– Fully-Automated External Defibrillators
• Wearable Cardioverter Defibrillators (WCDs)
• Global Defibrillators market forecast by end-user:
• Hospitals and Cardiac Centers
• Pre-hospital Services
• Public Access
• Home Care
• Other-End User
• Global Defibrillators National Market forecast 2019-2029, covering:
• North America
• US
• Canada
• Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
• Asia-Pacific:
• Japan
• China
• India
• Rest of Asia-Pacific
• Rest of the World
• Latin America
• Middle East
• Africa
• Analysis of the key factors driving and restraining the growth of the defibrillators market
• Assessment of selected leading companies, examining recent performance and outlooks:
• Abbott Laboratories
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Cardiac Science Corporation
• LivaNova PLC
• Medtronic PLC
• Nihon Kohden Corporation
• Phillips Healthcare
• Physio Control Inc.
• Zoll Medical Corporation
Visiongain’s study is intended for anyone requiring commercial analyses for the Global Defibrillators Market and leading companies. You find data, trends and predictions.
Buy our report today Global Defibrillators Market Forecast 2019-2029: External Defibrillators, Implantable Cardioverter Defibrillators, Transvenous ICD, Subcutaneous ICD, Single-Chamber ICD, Dual-Chamber ICD, Cardiac Resynchronization Therapy Defibrillators (CRT-D), Manual External Defibrillators, Automated External Defibrillators, Wearable Cardioverter Defibrillators.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
1. Report Overview
1.1 Global Defibrillators Market Overview
1.2 Global Defibrillators Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Primary Research
1.7.2 Secondary Research
1.7.3 Market Evaluation & Forecasting Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2. Introduction to the Defibrillators Market
2.1 Defibrillators Market Definition
2.2 Evolution of Defibrillators
2.2.1 Snapshot: Evolution of Defibrillators
2.2.2 History of Defibrillators
2.2.3 Currently Available Defibrillators
2.2.4 Future of Defibrillators
3. Global Defibrillators Market Forecast 2019 - 2029
3.1 Global Defibrillators Market Forecast to 2019 - 2029
3.2 Global Defibrillators Market Forecast by Product 2019 – 2029
3.3 Global Defibrillators Market Dynamics, 2018
4. Global Defibrillators Market by Product: Market Forecast 2019 - 2029
4.1 Implantable Cardioverter Defibrillators (ICDs) Market
4.1.1 Transvenous Implantable Cardioverter Defibrillators (T-ICDs)
4.1.2 Subcutaneous Implantable Cardioverter Defibrillators (S-ICD)
4.2 External Defibrillators Market
4.2.1 Manual External Defibrillators Market
4.2.2 Automated External Defibrillators (AEDs) Market
4.2.3 Wearable Cardioverter Defibrillators (WCDs)
5. Global Defibrillators Market by End-User: Market Forecast 2019 - 2029
5.1 Hospitals and Cardiac Centers Market
5.2 Pre-hospital Market
5.3 Public Access Sector Market
5.4 Home Care Market
5.5 Other End Use Sectors Market
6. Leading National Markets Forecast 2019 - 2029
6.1 North America Defibrillators Market Forecast 2019 - 2029
6.1.1 U.S. Defibrillators Market Forecast 2019 - 2029
6.1.2 Canada Defibrillators Market Forecast 2019 - 2029
6.2 Europe Defibrillators Market Forecast 2019 - 2029
6.2.1 UK Defibrillators Market Forecast 2019 - 2029
6.2.2 France Defibrillators Market Forecast 2019 - 2029
6.2.3 Germany Defibrillators Market Forecast 2019 - 2029
6.2.4 Italy Defibrillators Market Forecast 2019 - 2029
6.2.5 Spain Defibrillators Market Forecast 2019 - 2029
6.2.6 Rest of Europe Defibrillators Market Forecast 2019 - 2029
6.3 Asia-Pacific Defibrillators Market Forecast 2019 - 2029
6.3.1 China Defibrillators Market Forecast 2019 - 2029
6.3.2 Japan Defibrillators Market Forecast 2019 - 2029
6.3.3 India Defibrillators Market Forecast 2019 - 2029
6.3.4 Rest of APAC Defibrillators Market Forecast 2019 - 2029
6.4 Rest of the World (RoW) Defibrillators Market Forecast 2019 - 2029
6.4.1 Latin America Defibrillators Market Forecast 2019 - 2029
6.4.2 Middle East and Africa Defibrillators Market Forecast 2019 – 2029
7. Leading Companies in the Defibrillators Market
7.1 Medtronic PLC: Company Information
7.1.1 Medtronic PLC: Business Overview
7.1.2 Medtronic PLC: Financial Overview
7.1.3 Medtronic PLC: Product Portfolio
7.1.4 Medtronic PLC: Recent Developments
7.1.5 SWOT Analysis
7.2 Boston Scientific Corporation: Company Information
7.2.1 Boston Scientific Corporation: Business Overview
7.2.2 Boston Scientific Corporation: Financial Overview
7.2.3 Boston Scientific Corporation: Product Portfolio
7.2.4 Boston Scientific Corporation: Recent Developments
7.2.5 Boston Scientific Corporation: SWOT Analysis
7.3 Biotronik SE & Co. KG: Company Information
7.3.1 Biotronik SE & Co. KG: Business Overview
7.3.2 Biotronik SE & Co. KG: Product Portfolio
7.3.3 Biotronik SE & Co. KG: Recent Developments
7.4 Abbott Laboratories: Company Information
7.4.1 Abbott Laboratories: Business Overview
7.4.2 Abbott Laboratories: Financial Overview
7.4.3 Abbott Laboratories: Product Portfolio
7.4.4 Abbott Laboratories: Recent Developments
7.4.5 Abbott Laboratories: SWOT Analysis
7.5 LivaNova PLC: Company Information
7.5.1 LivaNova PLC: Business Overview
7.5.2 LivaNova PLC: Financial Overview
7.5.3 LivaNova PLC: Product Portfolio
7.5.4 LivaNova PLC: Recent Developments
7.6 Zoll Medical Corporation: Company Information
7.6.1 Zoll Medical Corporation: Business Overview
7.6.2 Zoll Medical Corporation: Financial Overview
7.6.3 Zoll Medical Corporation: Product Portfolio
7.6.4 Zoll Medical Corporation: Recent Developments
7.6.5 Zoll Medical Corporation: SWOT Analysis
7.7 Physio Control, Inc.: Company Information
7.7.1 Physio Control, Inc.: Business Overview
7.7.2 Physio Control, Inc.: Product Portfolio
7.7.3 Physio Control, Inc.: Recent Developments
7.8 Cardiac Science Corporation: Company Information
7.8.1 Cardiac Science Corporation: Business Overview
7.8.2 Cardiac Science Corporation: Product Portfolio
7.8.3 Cardiac Science Corporation: Recent Developments
7.9 Nihon Kohden Corporation: Company Information
7.9.1 Nihon Kohden Corporation: Business Overview
7.9.2 Nihon Kohden Corporation: Financial Overview
7.9.3 Nihon Kohden Corporation: Product Portfolio
7.9.4 Nihon Kohden Corporation: Recent Developments
7.10 Philips Healthcare: Company Information
7.10.1 Philips Healthcare: Business Overview
7.10.2 Philips Healthcare: Financial Overview
7.10.3 Philips Healthcare: Product Portfolio
7.10.4 Philips Healthcare: Recent Developments
7.10.5 Philips Healthcare: SWOT Analysis
8. Defibrillators Market Dynamics: SWOT and PEST Analysis
8.1 SWOT Analysis
8.1.1 Global Defibrillator Market Drivers
8.1.1.1 Availability of Technologically Advanced Defibrillators
8.1.1.2 Rapidly Growing Aging Population Leading to High Risk of Cardiovascular Diseases
8.1.1.3 Growing Incidence of Cardiovascular Diseases
8.1.1.4 Increasing Awareness and Training programmes Related to Defibrillators
8.1.2 Global Defibrillator Market Restraints
8.1.2.1 Concerns Associated with the Use of Defibrillators
8.1.2.2 Increasing Pricing Pressure on Manufacturers
8.1.2.3 Product Recalls
8.1.3 Global Defibrillator Market Opportunity
8.1.3.1 Focus on Emerging Markets
8.1.4 Global Defibrillator Market Trend
8.1.4.1 Mergers and Acquisitions
8.1.4.2 Development of ICDs and CRT-Ds with full-body MRI scans
8.2 PEST Analysis
8.2.1 Political
8.2.2 Economic
8.2.3 Social
8.2.4 Technological
9. Conclusions and Recommendations
9.1 The Global Defibrillator Market in 2017 and 2029
9.1.1 Current Leading Defibrillators Segments
9.1.2 Leading Defibrillators Companies
9.1.3 Leading Regional Markets
9.2 Global Defibrillators Market Forecast 2017-2029
9.3 The Future of the Defibrillators Market?
Appendices
Associated Visiongain Reports
Visiongain Report Sales Order Form
About Visiongain
Visiongain Report Evaluation Form
List of Tables
Table 3.1 Global Defibrillator Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
Table 3.2 Global Defibrillator Market Forecast by Product: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
Table 3.3 Defibrillator Market Forecast by Region: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
Table 3.4 Global Defibrillators Market Dynamics 2018
Table 4.1 Global Defibrillator Market Forecast 2017-2029 ($bn, AGR %, CAGR %)
Table 4.2 Global Implantable Cardioverter Defibrillators (ICDs) Forecast 2017-2029 ($bn, AGR %, CAGR %)
Table 4.3 Global Transvenous Implantable Cardioverter Defibrillator (T-ICD) Forecast 2017-2029 ($bn, AGR %, CAGR %)
Table 4.4 Global Single- Chamber Implantable Cardioverter Defibrillator Forecast 2017-2029 ($bn, AGR %, CAGR %)
Table 4.5 Global Dual- Chamber Implantable Cardioverter Defibrillator Forecast 2017-2029 ($bn, AGR %, CAGR %)
Table 4.6 Global Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) Forecast 2017-2029($bn, AGR %, CAGR %)
Table 4.7 Global Subcutaneous Implantable Cardioverter Defibrillators (S-ICD) Forecast 2017-2029 ($bn, AGR %, CAGR %)
Table 4.8 Global External Defibrillator Market Forecast 2017-2029 by Product ($bn, AGR %, CAGR %)
Table 4.9 Global Manual External Defibrillators Market Forecast 2017-2029 ($bn, AGR %, CAGR %)
Table 4.10 Global Automated External Defibrillators (AEDs) Market Forecast 2017-2029 ($bn, AGR %, CAGR %)
Table 4.11 Global Wearable Cardioverter External Defibrillators (WCDs) Market Forecast 2017-2029 ($bn, AGR %, CAGR %)
Table 5.1 Global Defibrillator Market by End-User 2017-2029 ($bn, AGR %, CAGR %)
Table 5.2 Global Hospitals and Cardiac Centers Defibrillator Market Forecast 2017-2029 ($bn, AGR %, CAGR %)
Table 5.3 Global Pre-Hospitals Defibrillator Market Forecast 2017-2029 ($bn, AGR %, CAGR %)
Table 5.4 Global Public Access Sector Defibrillator Market Forecast 2017-2029 ($bn, AGR %, CAGR %)
Table 5.5 Global Home Care Defibrillator Market Forecast 2017-2029 ($bn, AGR %, CAGR %)
Table 5.6 Global Other End User Market Forecast 2017-2029 ($bn, AGR %, CAGR %)
Table 6.1 Defibrillator Market Forecast Segmented by Regional Market: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
Table 6.2 North American Defibrillators Market Forecast Segmented by National Market: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
Table 6.3 U.S. Defibrillators Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
Table 6.4 Canada Defibrillators Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
Table 6.5 European Defibrillators Market Forecast Segmented by National Market: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
Table 6.6 U.K. Defibrillators Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
Table 6.7 France Defibrillators Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
Table 6.8 Germany Defibrillators Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
Table 6.9 Italy Defibrillators Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
Table 6.10 Spain Defibrillators Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
Table 6.11 Rest of Europe Defibrillators Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
Table 6.12 Asia-Pacific Defibrillators Market Forecast Segmented by National Market: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
Table 6.13 China Defibrillators Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
Table 6.14 Japan Defibrillators Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
Table 6.15 India Defibrillators Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
Table 6.16 Rest of APAC Defibrillators Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
Table 6.17 Rest of the World Defibrillators Market Forecast Segmented by National Market: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
Table 6.18 Latin America Defibrillators Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
Table 6.19 Middle East & Africa Defibrillators Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
Table 7.1 Medtronic PLC: Company Information
Table 7.2 Medtronic PLC: Product Portfolio
Table 7.3 Medtronic PLC: Recent Developments
Table 7.4 Medtronic PLC: Expansion
Table 7.5 Boston Scientific Corporation: Company Information
Table 7.6 Boston Scientific Corporation: Product Portfolio
Table 7.7 Boston Scientific Corporation: Recent Developments
Table 7.8 Biotronik SE & CO. KG: Company Information
Table 7.9 Biotronik SE & CO. KG: Product Portfolio
Table 7.10 Biotronik SE & CO. KG: Recent Developments
Table 7.11 Abbott Laboratories: Company Information
Table 7.12 Abbott Laboratories: Product Category
Table 7.13 Abbott Laboratories: Recent Developments
Table 7.14 LivaNova PLC: Company Information
Table 7.15 LivaNova PLC: Product Portfolio
Table 7.16 LivaNova PLC: Recent Developments
Table 7.17 Zoll Medical Corporation: Company Information
Table 7.18 Zoll Medical Corporatio: Product Category
Table 7.19 Zoll Medical Corporatio: Recent Developments
Table 7.20 Physio Control, Inc.: Company Information
Table 7.21 Physio Control, Inc.: Product Portfolio
Table 7.22 Physio Control, Inc.: Recent Developments
Table 7.23 Cardiac Science Corporation: Company Information
Table 7.24 Cardiac Science Corporation: Product Portfolio
Table 7.25 Cardiac Science Corporation: Recent Developments
Table 7.26 Nihon Kohden Corporation: Company Information
Table 7.27 Nihon Kohden Corporation: Product Portfolio
Table 7.28 Nihon Kohden Corporation: Recent Developments
Table 7.29 Philips Healthcare: Company Information
Table 7.30 Philips Healthcare: Product Portfolio
Table 7.31 Philips Healthcare: Recent Developments
Table 8.1 List of Product Recalls
Table 8.2 List of Mergers and Acquisitions in the Defibrillators Market
Table 8.3 MRI-Conditional ICDs and CRT-Ds Approved in 2016
List of Figures
Figure 1.1 Global Defibrillators Market Segmentation Overview
Figure 2.1 Snapshot: Evolution of Defibrillators
Figure 3.1 Global Defibrillator Market Forecast: Revenue ($bn), AGR (%), 2017-2029
Figure 3.2 Global Defibrillator Market by Product: 2017-2029 ($bn)
Figure 3.3 Defibrillator Market by Region: 2017-2029($bn, AGR %)
Figure 4.1 Global Defibrillator Market: 2017-2029 ($bn)
Figure 4.2 Global Defibrillator Market by Product: Market Share (%), 2018
Figure 4.3 Global Defibrillator Market by Product: Market Share (%), 2023
Figure 4.4 Global Defibrillator Market by Product: Market Share (%), 2029
Figure 4.5 Global Implantable Cardioverter Defibrillators Market: 2017-2029 ($bn, AGR %)
Figure 4.6 Global Implantable Cardioverter Defibrillators (ICDs) Market by Sub Segment: Market Share (%), 2018
Figure 4.7 Global Implantable Cardioverter Defibrillators (ICDs) Market by Sub Segment: Market Share (%), 2023
Figure 4.8 Global Implantable Cardioverter Defibrillators (ICDs) Market by Sub Segment: Market Share (%), 2029
Figure 4.9 Global Transvenous Implantable Cardioverter Defibrillators Market: 2017-2029 ($bn, AGR %)
Figure 4.10 Global Transvenous Implantable Cardioverter Defibrillator (T-ICD) Market by
Sub Segment: Market Share (%), 2018
Figure 4.11 Global Transvenous Implantable Cardioverter Defibrillator (T-ICD) Market by
Sub Segment: Market Share (%), 2023
Figure 4.12 Global Transvenous Implantable Cardioverter Defibrillator (T-ICD) Market by
Sub Segment: Market Share (%), 2029
Figure 4.13 Global Single-Chamber Implantable Cardioverter Defibrillator Market
Forecast: 2017-2029 ($bn, AGR %)
Figure 4.14 Global Dual-Chamber Implantable Cardioverter Defibrillator Market Forecast:
2017-2029 ($bn, AGR %)
Figure 4.15 Global Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) Market
Forecast: 2017-2029 ($bn, AGR %)
Figure 4.16 Global Subcutaneous Implantable Cardioverter Defibrillators (CRT-Ds)
Market Forecast: 2017-2029 ($bn, AGR %)
Figure 4.17 Global External Defibrillators Market Forecast 2017-2029 ($bn, AGR %)
Figure 4.18 Global External Defibrillators Market by Sub Segment: Market Share (%),
2018
Figure 4.19 Global External Defibrillators Market by Sub Segment: Market Share (%),
2023
Figure 4.20 Global External Defibrillators Market by Sub Segment: Market Share (%),
2029
Figure 4.21 Global Manual External Defibrillators Forecast 2017-2029 ($bn, AGR %)
Figure 4.22 Global Automated External Defibrillators Market by Sub Segment: Market
Share (%), 2018
Figure 4.23 Global Automated External Defibrillators Market by Sub Segment: Market
Share (%), 2023
Figure 4.24 Global Automated External Defibrillators Market by Sub Segment: Market
Share (%), 2029
Figure 4.25 Global Wearable Cardioverter External Defibrillators Forecast 2017-2029
($bn, AGR %)
Figure 5.1 Global Defibrillators Market by End-User: 2017-2029 ($bn)
Figure 5.2 Global Defibrillators Market by End User: Market Share (%), 2018
Figure 5.3 Global Defibrillators Market by End User: Market Share (%), 2023
Figure 5.4 Global Defibrillators Market by End User: Market Share (%), 2029
Figure 5.5 Global Hospitals and Cardiac Centers Defibrillators Market Forecast 2017-
2029 ($bn, AGR %)
Figure 5.6 Global Pre-Hospitals Defibrillators Market Forecast 2017-2029 ($bn, AGR %)
Figure 5.7 Global Public Access Sector Defibrillators Market Forecast 2017-2029 ($bn,
AGR %)
Figure 5.8 Global Home Care Defibrillator Market Forecast 2017-2029 ($bn, AGR %)
Figure 5.9 Global Other End User Market Forecast 2017-2029 ($bn, AGR %)
Figure 6.1 Defibrillators Market Forecast Segmented by Regional Market: 2017-2029
($bn)
Figure 6.2 Global Defibrillator Market by Region: Market Share (%), 2018
Figure 6.3 Global Defibrillator Market by Region: Market Share (%), 2023
Figure 6.4 Global Defibrillator Market by Region: Market Share (%), 2029
Figure 6.5 North American Defibrillators Market Forecast: 2017-2029 ($bn, AGR %)
Figure 6.6 North American Defibrillators Market Forecast Segmented by National Market:
2017-2029 ($bn)
Figure 6.7 North American Defibrillator Market by Country: Market Share (%), 2018
Figure 6.8 North American Defibrillator Market by Country: Market Share (%), 2023
Figure 6.9 North American Defibrillator Market by Country: Market Share (%), 2029
Figure 6.10 U.S. Defibrillators Market Forecast: 2017-2029 ($bn, AGR %)
Figure 6.11 Canada Defibrillators Market Forecast: 2017-2029 ($bn, AGR %)
Figure 6.12 European Defibrillators Market Forecast: 2017-2029 ($bn, AGR %)
Figure 6.13 European Defibrillators Market Forecast Segmented by National Market:
2017-2029 ($bn)
Figure 6.14 European Defibrillators Market by Country: Market Share (%), 2018
Figure 6.15 European Defibrillators Market by Country: Market Share (%), 2023
Figure 6.16 European Defibrillators Market by Country: Market Share (%), 2029
Figure 6.17 U.K. Defibrillators Market Forecast: 2017-2029 ($bn, AGR %)
Figure 6.18 France Defibrillators Market Forecast: 2017-2029 ($bn, AGR %)
Figure 6.19 Germany Defibrillators Market Forecast: 2017-2029 ($bn, AGR %)
Figure 6.20 Italy Defibrillators Market Forecast: 2017-2029 ($bn, AGR %)
Figure 6.21 Spain Defibrillators Market Forecast: 2017-2029 ($bn, AGR %)
Figure 6.22 Rest of Europe Defibrillators Market Forecast: 2017-2029 ($bn, AGR %)
Figure 6.23 Asia-Pacific Defibrillators Market Forecast: 2017-2029 ($bn, AGR %)
Figure 6.24 Asia-Pacific Defibrillators Market Forecast Segmented by National Market:
2017-2029 ($bn)
Figure 6.25 APAC Defibrillators Market by Country: Market Share (%), 2018
Figure 6.26 APAC Defibrillators Market by Country: Market Share (%), 2023
Figure 6.27 APAC Defibrillators Market by Country: Market Share (%), 2029
Figure 6.28 China Defibrillators Market Forecast: 2017-2029 ($bn, AGR %)
Figure 6.29 Japan Defibrillators Market Forecast: 2017-2029 ($bn, AGR %)
Figure 6.30 India Defibrillators Market Forecast: 2017-2029 ($bn, AGR %)
Figure 6.31 Rest of APAC Defibrillators Market Forecast: 2017-2029 ($bn, AGR %)
Figure 6.32 Rest of the World Defibrillators Market Forecast: 2017-2029 ($bn, AGR %)
Figure 6.33 Rest of the World Defibrillators Market Forecast: 2017-2029 ($bn)
Figure 6.34 RoW Defibrillator Market by Region: Market Share (%), 2018
Figure 6.35 RoW Defibrillator Market by Region: Market Share (%), 2023
Figure 6.36 RoW Defibrillator Market by Region: Market Share (%), 2029
Figure 6.37 Latin American Defibrillators Market Forecast: 2017-2029 ($bn, AGR %)
Figure 6.38 Middle East & Africa Defibrillators Market Forecast: 2017-2029 ($bn, AGR %)
Figure 7.1 Medtronic PLC: Financial Overview 2014-2018
Figure 7.2 Medtronic PLC: Segment Overview - 2018
Figure 7.3 Medtronic PLC: Geographical Overview - 2018
Figure 7.4 Medtronic PLC: SWOT Analysis
Figure 7.5 Boston Scientific Corporation: Financial Overview 2013-2017
Figure 7.6 Boston Scientific Corporation: Segment Overview - 2018
Figure 7.7 Boston Scientific Corporation: Geographic Overview - 2018
Figure 7.8 Boston Scientific Corporation: SWOT Analysis
Figure 7.9 Abbott Laboratories: Financial Overview 2013-2017
Figure 7.10 Abbott Laboratories: Segment Overview - 2018
Figure 7.10 Abbott Laboratories: Geographic Overview - 2018
Figure 7.12 Abbott Laboratories: SWOT Analysis
Figure 7.13 LivaNova PLC: Financial Overview 2013-2017
Figure 7.14 LivaNova PLC: Segment Overview - 2018
Figure 7.15 LivaNova PLC: Geographic Overview - 2018
Figure 7.16 Zoll Medical Corporation: Financial Overview
Figure 7.17 Zoll Medical Corporation: SWOT Analysis
Figure 7.18 Nihon Kohden Corporation: Financial Overview 2013-2017
Figure 7.19 Nihon Kohden Corporation: Segment Overview - 2018
Figure 7.20 Nihon Kohden Corporation Geographic Overview - 2018
Figure 7.21 Philips Healthcare: Financial Overview 2013 – 2017
Figure 7.22 Nihon Kohden Corporation: Segment Overview - 2018
Figure 7.23 Nihon Kohden Corporation Geographic Overview - 2018
Figure 7.24 Philips Healthcare: SWOT Analysis
Figure 8.1 Number of Cardiovascular Deaths (Million) by Region (2015 to 2030)
Figure 9.1 Global Defibrillator Market: 2017-2029 ($bn, AGR %)
Figure 9.2 Global Defibrillator Market by Product: 2017-2029 ($bn)
Figure 9.3 Defibrillator Market by Region: 2017-2029 ($bn)
Abbott Laboratories
ADS, Inc.
Air Force
Alere Inc.
American Heart Association (AHA)
Apama Medical Inc.
Asahi Kasei Group Company
Aska Equipments Ltd.
Augmenix, Inc.
Aurora Capital Group
Aurora Resurgence
Aziyo
Badger State Sheriffs’ Association (BSSA)
Barcelona City Council
Bavarian Red Cross
BIOTRONIK
BIOTRONIK SE & Co. KG
Boston Scientific Corporation
British Red Cross
Caisson Interventional, LLC.
Cardiac Science Corporation
China Food and Drug Administration
Crospon
Cyberonics Inc.
Department of Education, UK
European Heart Rhythm Association
Farong Shen in Zhejiang Lucheng Hospital
Groveland Fire Department
Health Canada
Heart Rhythm Society (HRS)
HEART UK
HeartSine Technologies
ImThera Medical
Japanese Ministry of Health, Labour and Welfare
Johns Hopkins University
Koninklijke Philips N.V.
Lek
Life-Assist, Inc.
Lippert Components, Inc.
LivaNova Plc
Mazor Robotics
Medtronic Emergency Response Systems, Inc.
Medtronic plc
Metrax GmbH
Metrax GmbH
MicroPort Scientific
MicroPort Scientific Corporation
MicroPort Sorin CRM (Shanghai) Co. Ltd
Mountain Rescue Association of Slovenia (MRAS)
National Health Service
National Taxi Association
Nihon Kohden
Nihon Kohden Corporation
Nutrino
nVision Medical Corporation
Philips Healthcare
Physio-Control, Inc.
Progetti Srl
Promega Srl.
Quinton Cardiology Systems, Inc.
Sand Holdco Limited
Sand Holdco PLC
Saudi Heart Rhythm Society
Securus Medical Group, Inc.
Singapore Civil Defence Force (SCDF)
Singapore Heart Foundation
Smith & Nephew
Sorin S.p.A
Spacelabs Healthcare
St. Jude Medical, Inc.
Stentor, Inc.
Stryker Corporation
Symetis SA
TandemLife
The Spectranetics Corporation
United Nations
United States Food and Drugs Administration
US Army
VisionSense
Walmart Canada
Wei Hua in Beijing Fuwai Hospital
World Health Organization
World Heart Federation (WHF)
ZOLL Medical Corporation
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
